CN Stock MarketDetailed Quotes

002589 Realcan Pharmaceutical Group

Watchlist

2.95
+0.12+4.24%

Market Closed Apr 30 15:00 CST

4.44BMarket Cap226.92P/E (TTM)

Realcan Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Realcan Pharmaceutical Group Q1 2025 Earnings Date

Currency：CNYApr 30, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	1.76B	--
		-12.98%
EPS	--	<0.01	--
		-6.93%

Analyst Rating

No Data

Realcan Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Apr 30, 2019	2019/Q1	8.742B / 7.504B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 30, 20192019/Q18.742B / 7.504B--

Realcan Pharmaceutical Group Earnings Reports

Ruikang Pharmaceutical: Report for the first quarter of 2025

Apr 29 12:00 ET

Realcan Pharmaceutical Group: 2024 Annual Report

Apr 23 12:00 ET

Realcan Pharmaceutical Group: Summary of the 2024 Annual Report